RESTORx ANTI-ANXIETY SUPPORT
Are you on anti-anxiety medication and experiencing side effects such as:
- Hypersomnia (trouble staying awake)
The contribution of sleep disturbance to the onset, exacerbation, and maintenance of mood
and anxiety disorders has received greater attention in the past decade.1
Insomnia is present in 20-40% of individuals with mental illness.
Even higher rates were reported in mood disorder and anxiety:
50-70% of patients with mood disorders,
70-90% of patients with anxiety
Anti-anxiety Support contains natural ingredients that may reduce
the impact of side effects, encouraging adherence to prescription medication.
SOLAL® RestorX Anti-Anxiety Support has 3 hero ingredients, in their optimal doses, to restore, reduce, enhance and oppose side effects caused by anti-anxiety medication.
Functions as a cofactor for enzymes that convert tryptophan into serotonin and tyrosine into norepinephrine / noradrenaline. Can heighten serotonin function by slowing destruction of brain tryptophan. Helps form compounds involved in brain energy metabolism. Involved in the synthesis of dopamine
Vitamin D3 affects cholinergic activity in several brain regions and may have a role in the neuroendocrine regulation of certain aspects of anterior pituitary function
Important intracellular messenger, cofactor for enzymes and release of neurotransmitters
RESTORx ANTI-ANXIETY SUPPORT
To be used in conjunction with prescibed anti-anxiety medicines, to reduce their side effects by restoring medication-induced nutrient deficiencies.
|Each Capsule Contains||Amount Available in RESTORx Anti-Anxiety Support|
|Magnesium (Magnesium bisglycinate)||20 mg|
|Calcium (Calcium glycinate)||40 mg|
|Folate (L-5-Methyltetrahydrofolate calcium)||500 μg|
|Vitamin D3||1000 IU|
DOSE: Adults: Take one capsule daily after a meal.
For full prescribing information, refer to the package insert/product information approved by the regulatory authority. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.References:
- 1. Treatment | Anxiety and Depression Association of America. Accessed on August 2018. Available on https://adaa.org/finding-help/treatment.
- 2. South Africa A Heaven For Anxiety Disorders. Accessed on August 2018. Available on http://www.sadag.org/index.php?option=com_content&view=article&id=577:south-africa-a-heaven-for-anxiety-disorders&catid=78&Itemid=161.
- 3. Staner, L. 2003. Sleep and anxiety disorders. Dialogues in Clinical Neuroscience. 5(3):249-258.
- 4. Locke, A.B., Kirst, N. et al. 2015. Diagnosis and Management of Generalized Anxiety Disorder and Panic Disorder in Adults. American Family Physician. 91(9):618-624.
- 5. Bandelow, B., Sher, L. et al. 2012. Guidelines for the pharmacological treatment of anxiety disorders, obsessive – compulsive disorder and posttraumatic stress disorder in primary care International Journal of Psychiatry in Clinical Practice. 16: 77–84.
- 6. Alberti, S., Chiesa, A. et al. 2015. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a metaanalysis. J Clin Psychopharmacol. 35(3):296-303.
- 7. Mayers, A.G., and Baldwin, D.S. 2015. Antidepressants and their effect on sleep. Hum Psychopharmacol Clin Exp. 20: 533–559.
- 8. Wichniak, A., Wierzbicka, A. et al. 2012. Sleep and antidepressant treatment. Curr Pharm Des. 18(36):5802-17.
- 9. Paredes, S.D., Barriga, C. et al. 2009. Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model. International Journal of Tryptophan Research. 2:23–36.
- 10. Cajochen, C., Kra ̈uchi, K. et al. 2003. Role of Melatonin in the Regulation of Human Circadian Rhythms and Sleep Journal of Neuroendocrinology. 15:432–437.
- 11. Davison K.M., Chandrasekera, U. et al. 2012. The Role of Nutrition in Mental Health Promotion and Prevention (1). Toronto: Dietitians of Canada, 2012. Access on August 2018. Available on www.dietitians.ca/mentalhealth.